会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 18. 发明授权
    • Biotherapy of cancer by targeting TP-3/P80
    • 通过靶向TP-3 / P80进行癌症生物治疗
    • US5690935A
    • 1997-11-25
    • US372608
    • 1995-01-13
    • Fatih M. UckunPeter M. Anderson
    • Fatih M. UckunPeter M. Anderson
    • A61K47/48A61P35/00A61K39/44C07K14/415C07K16/28C12N15/13
    • A61K47/48469Y10S530/866
    • Cytotoxic biotherapeutic agents effective for treating certain types of cancer in humans are provided which comprise the TP-3 murine monoclonal antibody chemically conjugated to pokeweed antiviral protein (PAP). The invention further provides a method which utilizes the disclosed cytotoxic biotherapeutic agents to systemically treat cancer patients. With slight modifications the method of the present invention should be generally applicable to preparation and use of other cytotoxic biotherapeutic agents using chemical or recombinant derivatives of the TP-3 or TP-1 antibodies or PAP toxin. The invention is applicable to cancer patients who express the p80 antigen recognized by the TP-1/TP-3 antibodies either on the surface of their tumor cells or on the tumor blood vessels.
    • 提供了有效治疗人类某些类型癌症的细胞毒性生物治疗剂,其包含与pokeweed抗病毒蛋白(PAP)化学偶联的TP-3鼠单克隆抗体。 本发明进一步提供利用所公开的细胞毒性生物治疗剂系统地治疗癌症患者的方法。 通过轻微修改,本发明的方法应通常适用于使用TP-3或TP-1抗体或PAP毒素的化学或重组衍生物制备和使用其它细胞毒性生物治疗剂。 本发明适用于在肿瘤细胞表面或肿瘤血管上表达由TP-1 / TP-3抗体识别的p80抗原的癌症患者。